Page 218 - Genentech News Today

Second, the Court reversed the district court's summary judgment that the prior art cited by Avery does not invalidate the asserted patent claim and remanded for further proceedings.

Precedential Federal Circuit Opinions - 1.  ADASA INC. v. AVERY DENNISON CORPORATION [OPINION] (2022-1092, 12/16/2022) (Moore, Hughes, and Stark) - Moore,...

A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent...

A Phase II trial has led to the FDA approval of atezolizumab for individuals over two years old with advanced alveolar soft part sarcoma.

MONDAY, Jan. 2, 2023 (HealthDay News) -- Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big

/PRNewswire/ -- The Advocate: Supporting the Patient Voice is excited to announce the first ever Top Overall Pharmaceutical Patient Advocacy Organizations in...

Award winning short film directed by disabled award winning filmmaker Emmitt H Thrower has a public virtual screening.

Juli Miller: Good morning and welcome to Adaptimmunes conference call to discuss our third quarter 2022 financial results and business update.

Protein could yield potential therapeutic strategy to detect and prevent cancer therapy-associated heart failure

A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS).